February 21, 2017 9:04 PM ET


Company Overview of Anosys Inc.

Company Overview

As of December 31, 2005, Anosys Inc. was acquired by Chromos Molecular Systems Inc. Anosys Inc. develops therapeutic vaccines for the treatment of cancer, infectious, and autoimmune diseases. Its products are based on exosomes, which are small vesicles that contain components required to activate the innate and cellular immune responses necessary to fight disease. The company is based in Menlo Park, California and has an additional office in Evry, France.

1014 Hamilton Court

Menlo Park, CA 94025

United States





Key Executives for Anosys Inc.

Anosys Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Anosys Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.